Prevalence and impact of extended-spectrum |
Kim, Sun Jong
(Department of Internal Medicine, Konkuk University School of Medicine)
Park, Ki-Ho (Division of Infectious Diseases, Department of Internal Medicine, Kyung Hee University Medical Center) Chung, Jin-Won (Division of Infectious Diseases, Department of Internal Medicine, Chung-Ang University Hospital) Sung, Heungsup (Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine) Choi, Seong-Ho (Division of Infectious Diseases, Department of Internal Medicine, Chung-Ang University Hospital) Choi, Sang-Ho (Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine) |
1 | Choi SH, Lee JE, Park SJ, et al. Emergence of antibiotic resistance during therapy for infections caused by Enterobacteriaceae producing AmpC beta-lactamase: implications for antibiotic use. Antimicrob Agents Chemother 2008;52:995-1000. DOI ScienceOn |
2 | Jarvis WR, Martone WJ. Predominant pathogens in hospital infections. J Antimicrob Chemother 1992;29 Suppl A:19-24. |
3 | Sanders WE Jr, Sanders CC. Enterobacter spp.: pathogens poised to flourish at the turn of the century. Clin Microbiol Rev 1997;10:220-241. |
4 | Chow JW, Fine MJ, Shlaes DM, et al. Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med 1991;115:585-590. DOI ScienceOn |
5 | Choi SH, Lee JE, Park SJ, et al. Prevalence, microbiology, and clinical characteristics of extended-spectrum beta- lactamase-producing Enterobacter spp., Serratia marcescens, Citrobacter freundii, and Morganella morganii in Korea. Eur J Clin Microbiol Infect Dis 2007;26:557-561. DOI |
6 | Cheong HS, Ko KS, Kang CI, Chung DR, Peck KR, Song JH. Prevalence of extended-spectrum beta-lactamase among Enterobacteriacae blood isolates with inducible AmpC beta-lactamase. Infect Chemother 2010;42:280-284. DOI |
7 | Kanamori H, Yano H, Hirakata Y, et al. Molecular characteristics of Extended-spectrum beta-lactamases and qnr determinants in Enterobacter species from Japan. PLoS One 2012;7:e37967. DOI |
8 | Pai H, Hong JY, Byeon JH, Kim YK, Lee HJ. High prevalence of extended-spectrum beta-lactamase-producing strains among blood isolates of Enterobacter spp. collected in a tertiary hospital during an 8-year period and their antimicrobial susceptibility patterns. Antimicrob Agents Chemother 2004;48:3159-3161. DOI ScienceOn |
9 | Kim J, Lim YM. Prevalence of derepressed ampC mutants and extended-spectrum beta-lactamase producers among clinical isolates of Citrobacter freundii, Enterobacter spp., and Serratia marcescens in Korea: dissemination of CTX-M-3, TEM-52, and SHV-12. J Clin Microbiol 2005;43:2452-2455. DOI ScienceOn |
10 | Stuart JC, Diederen B, Al Naiemi N, et al. Method for phenotypic detection of extended-spectrum beta-lactamases in enterobacter species in the routine clinical setting. J Clin Microbiol 2011;49:2711-2713. DOI ScienceOn |
11 | Park YJ, Park SY, Oh EJ, et al. Occurrence of extended- spectrum beta-lactamases among chromosomal AmpC-producing Enterobacter cloacae, Citrobacter freundii, and Serratia marcescens in Korea and investigation of screening criteria. Diagn Microbiol Infect Dis 2005;51:265-269. DOI ScienceOn |
12 | Ho PL, Shek RH, Chow KH, et al. Detection and characterization of extended-spectrum beta-lactamases among bloodstream isolates of Enterobacter spp. in Hong Kong, 2000-2002. J Antimicrob Chemother 2005;55:326-332. DOI ScienceOn |
13 | Song EH, Park KH, Jang EY, et al. Comparison of the clinical and microbiologic characteristics of patients with Enterobacter cloacae and Enterobacter aerogenes bacteremia: a prospective observation study. Diagn Microbiol Infect Dis 2010;66:436-440. DOI ScienceOn |
14 | Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility tests: 16th informational supplement, CLSI M100-S16. Wayne: Clinical and Laboratory Standards Institute, 2006. |
15 | Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-383. DOI ScienceOn |
16 | Jacoby GA, Han P. Detection of extended-spectrum beta- lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli. J Clin Microbiol 1996;34:908-911. |
17 | Oh CE, Hong JS, Bae IK, et al. Dissemination of CTX-M type extended-spectrum beta-lactamases and emergence of CTX-M-12 in Escherichia coli. Korean J Lab Med 2005;25:252-258. |
18 | McCabe WR, Jackson GG. Gram-negative bacteremia: I. etiology and ecology. Arch Intern Med 1962;110:847-855. DOI |
19 | Bone RC, Sibbald WJ, Sprung CL. The ACCP-SCCM consensus conference on sepsis and organ failure. Chest 1992;101:1481-1483. DOI |
20 | Cheong HS, Ko KS, Kang CI, Chung DR, Peck KR, Song JH. Clinical significance of infections caused by extended- spectrum beta-lactamase-producing Enterobacteriaceae blood isolates with inducible AmpC beta-lactamase. Microb Drug Resist 2012;18:446-452. DOI ScienceOn |
21 | Lee CC, Lee NY, Yan JJ, et al. Bacteremia due to extended- spectrum-beta-lactamase-producing Enterobacter cloacae: role of carbapenem therapy. Antimicrob Agents Chemother 2010;54:3551-3556. DOI ScienceOn |
22 | Qureshi ZA, Paterson DL, Pakstis DL, et al. Risk factors and outcome of extended-spectrum beta-lactamase-producing Enterobacter cloacae bloodstream infections. Int J Antimicrob Agents 2011;37:26-32. DOI ScienceOn |
23 | Ohmagari N, Hanna H, Graviss L, et al. Risk factors for infections with multidrug-resistant Pseudomonas aeruginosa in patients with cancer. Cancer 2005;104:205-212. DOI ScienceOn |
24 | Livermore DM. Current epidemiology and growing resistance of gram-negative pathogens. Korean J Intern Med 2012;27:128-142. DOI |
25 | Gudiol C, Tubau F, Calatayud L, et al. Bacteraemia due to multidrug-resistant Gram-negative bacilli in cancer patients: risk factors, antibiotic therapy and outcomes. J Antimicrob Chemother 2011;66:657-663. DOI ScienceOn |
26 | Huh K, Kang CI, Kim J, et al. Risk factors and treatment outcomes of bloodstream infection caused by extended- spectrum cephalosporin-resistant Enterobacter species in adults with cancer. Diagn Microbiol Infect Dis 2014;78:172-177. DOI ScienceOn |
27 | Kang CI, Song JH. Antimicrobial resistance in Asia: current epidemiology and clinical implications. Infect Chemother 2013;45:22-31. DOI ScienceOn |
![]() |